Investor Updates and Exclusive Profile on Guided Therapeutics, Inc. (OTCQB: GTHP)

NEW YORK, NY -- August 7, 2015 -- InvestorsHub NewsWire -- Small Cap Street makes the connection between sophisticated investors and high quality micro and small cap companies that are currently undervalued. We are an issuer of reports written by experienced financial analysts and who provide a straight forward assessment of a profiled company. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges.

*Special Analyst Profile*

Guided Therapeutics, Inc. is Making Progress in the Battle with Cervical Cancer

Guided Therapeutics, Inc. (OTCQB: GTHP) is the developer of the LuViva Advanced Cervical Scan, a rapid and painless test for the early detection of disease that leads to cervical cancer. LuViva eliminates false positive Pap and HPV results and can discover cervical disease missed by existing tests. LuViva works by shining light on the cervical area and reading the returned light with a spectrometer. LuViva looks for chemical and physical markers of precancer. Unlike other tests, the device does not require a painful tissue sample and results are known immediately. LuViva is approved for sale in Canada, Mexico, the European Union and several other countries around the world.

GTHP is currently working toward FDA approval of LuViva for use in the USA. In the following report you can read about the company, their technology and future prospects for investors: http://bit.ly/_GTHP_Special_Profile

4 Brief Reports:

Eventure Interactive, Inc. (OTCQB: EVTI) offers technologies that are robust, yet simple-to-use which address inefficiencies in the social marketplace by enabling captured memories to be centrally stored and effortlessly shared among event attendees in a secure, real-time environment.

The company has recently made plans to increase its number of authorized shares and negotiated financing agreements. Get the details of these corporate moves in the report that follows: http://bit.ly/_EVTI_Brief_Report

American Green, Inc. (OTCBB: ERBB) is behind the ZaZZZ Automated Dispensary, OneBode International, and its proprietary Debit Card. American Green, has begun rolling out products within two sectors of the burgeoning medical and adult-use cannabis business. American Green has also developed a proprietary product line and debit card called the ZaZZZ Card. The card has been designed to be used in the company's automated dispensary machines. LA Laker basketball star and 2-time MVP, Steve Nash, is a major shareholder of the company.

The company has recently announced several moves it made to facilitate its growth and streamline its operations. Read about the moves the company made in the report you can read here: http://bit.ly/_ERBB_Brief_Report

Anavex Life Sciences Corp. (OTCQX: AVXL) is a biopharmaceutical company dedicated to the development of novel drug candidates to treat central nervous system (CNS) diseases and various types of cancer. Anavex’s lead drug candidates, ANAVEX 2-73 and ANAVEX PLUS, the combination of ANAVEX 2-73 and donepezil (Aricept®), are currently in a Phase 2a clinical trial for Alzheimer’s disease.

Get the information you need about the development benchmarks achieved in the company’s product line here, in this report: http://bit.ly/_AVXL_Brief_Report

Propanc Health Group Corp. (OTCQB: PPCH) is focused on developing new cancer treatments for patients suffering from pancreatic and colorectal cancers. Propanc have developed a formulation of anti-cancer compounds which exert a number of effects designed to control or prevent tumors from recurring and spreading throughout the body. Propanc's products involve or employ proenzymes, which are inactive precursors of enzymes.

PPCH has news regarding an up-list to OTCQB and a restructuring of its common shares. Read about these developments in this report: http://bit.ly/_PPCH_Brief_Report

Forward-Looking Disclaimer
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.

Compliance Procedure
Content is researched, written and reviewed on a best-effort basis by a 3rd party research analyst. However, we are only human and may make mistakes. This report was prepared for informational purposes only. A full disclaimer can be found by viewing the full analyst report. We do not engage in high frequency trading or hold any positions of profiled company.
For more information and services provided beyond this release please use contact information provided below. If you notice any errors or omissions, please notify us below.

Source: Small Cap Street

Contact: editor@smallcapstreet.com